Eligibility is open to researchers studying Marfan syndrome, VEDS, LDS, EDS, and other genetic aortic and vascular conditions. The grant requires involvement of an institutionally funded graduate student or fellow, and is open to international researchers. Collaboration across different disciplines and with pharmaceutical partners is highly desirable.